Prime Medicine, Inc.
PRMENASDAQHealthcare● Active
$2.96
$-0.10(-3.27%)
Market Cap$534627652
P/E Ratio—
52W High$6.94
52W Low$1.4
Prime Medicine, Inc. (PRME) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PRME · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($201.14M) | ($195.88M) | ($198.13M) | ($121.82M) | ($165.37M) |
| Depreciation & Amort. | $5.38M | $6.13M | $4.65M | $2.22M | $0.57M |
| Stock-Based Comp. | $29.27M | $26.07M | $13.91M | $6.46M | $1.75M |
| Change in Working Capital | ($5.34M) | $31.08M | $2.65M | ($35.40M) | $31.18M |
| Net Cash from Operations | ($162.56M) | ($122.86M) | ($165.41M) | ($131.83M) | ($34.08M) |
| Investing Activities | |||||
| Capital Expenditure | ($4.53M) | ($7.29M) | ($8.72M) | ($16.09M) | ($4.15M) |
| Purchases of Investments | ($205.41M) | ($129.45M) | ($104.95M) | ($123.34M) | ($81.98M) |
| Sales of Investments | $101.18M | $204.20M | $132.56M | $93.00M | $13.00M |
| Net Cash from Investing | ($108.76M) | $68.46M | $18.71M | ($47.10M) | ($73.63M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $151.51M | $195.88M | $0.66M | $181.49M | $269.28M |
| Free Cash Flow | |||||
| Free Cash Flow | ($167.09M) | ($130.16M) | ($174.14M) | ($147.92M) | ($38.23M) |
| FCF Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Prime Medicine, Inc. data
About Prime Medicine, Inc. (PRME) Cash Flow Statement
Prime Medicine, Inc. generated operating cash flow of ($0.16B) and free cash flow of ($0.17B) for 2025 — a FCF margin of -3607.41%. Capital expenditure was ($0.00B).
Frequently asked questions
PRME · 4 questionsPrime Medicine, Inc. generated free cash flow of ($0.17B) for 2025, down 28.4% year-over-year.
PRME free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10